We did not find a difference in circulating ACE2 activity in patients treated with ACEi, with ARB, or without RAAS inhibitors, suggesting that the role for medication is insignificant in determining circulating ACE2 activity in severe AS patients. Here, ACE2 is linked to aortic stenosis.